These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 3007564)

  • 1. Inhibition of interleukin-2-induced T-cell proliferation by sera from patients with the acquired immune deficiency syndrome.
    Donnelly RP; Tsang KY; Galbraith GM; Wallace JI
    J Clin Immunol; 1986 Jan; 6(1):92-101. PubMed ID: 3007564
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Humoral-mediated suppression of interleukin 2-dependent target cell proliferation in acquired immune deficiency syndrome (AIDS): interference with normal IL-2 receptor expression.
    Donnelly RP; La Via MF; Tsang KY
    Clin Exp Immunol; 1987 Jun; 68(3):488-99. PubMed ID: 3115647
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prospective study of cytotoxic T lymphocyte responses to influenza and antibodies to human T lymphotropic virus-III in homosexual men. Selective loss of an influenza-specific, human leukocyte antigen-restricted cytotoxic T lymphocyte response in human T lymphotropic virus-III positive individuals with symptoms of acquired immunodeficiency syndrome and in a patient with acquired immunodeficiency syndrome.
    Shearer GM; Salahuddin SZ; Markham PD; Joseph LJ; Payne SM; Kriebel P; Bernstein DC; Biddison WE; Sarngadharan MG; Gallo RC
    J Clin Invest; 1985 Oct; 76(4):1699-704. PubMed ID: 2997287
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A model for the selective loss of major histocompatibility complex self-restricted T cell immune responses during the development of acquired immune deficiency syndrome (AIDS).
    Shearer GM; Bernstein DC; Tung KS; Via CS; Redfield R; Salahuddin SZ; Gallo RC
    J Immunol; 1986 Oct; 137(8):2514-21. PubMed ID: 3489767
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sera from patients with the acquired immunodeficiency syndrome inhibit production of interleukin-2 by normal lymphocytes.
    Siegel JP; Djeu JY; Stocks NI; Masur H; Gelmann EP; Quinnan GV
    J Clin Invest; 1985 Jun; 75(6):1957-64. PubMed ID: 2989337
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Quantitative estimation by a standardized enzyme-linked immunosorbent assay of human T-cell lymphotropic virus type I antibodies in adult T-cell leukemia and acquired immune deficiency syndrome.
    Halbert SP; Poiesz B; Friedman-Kien AE; Montagna R; Blattner WA; Anken M
    J Clin Microbiol; 1986 Feb; 23(2):212-6. PubMed ID: 3009530
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characterization of immunologic function in homosexual men with persistent, generalized lymphadenopathy and acquired immune deficiency syndrome.
    Burkes RL; Abo W; Levine AM; Linker-Israeli M; Parker JW; Gill PS; Krailo M; Horwitz DA
    Cancer; 1987 Feb; 59(4):731-8. PubMed ID: 3492262
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Antibodies against human T-cell leukemia virus type III in acquired immunodeficiency syndrome and persistent lymphadenopathy].
    Wernicke D; v d Helm K; Abb J; Eberle J; Zoulek G; Pleyl G; Deinhardt F; Riethmüller G; Ziegler-Heitbrock HW; Rieber EP
    Dtsch Med Wochenschr; 1984 Nov; 109(45):1709-11. PubMed ID: 6094134
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Presence of antibodies to human lymphoma-leukemia virus (HTLV-I) in Germans with symptoms of the acquired immunodeficiency syndrome (AIDS).
    Born M; von der Helm K; Wernicke D; Deinhardt F
    J Med Virol; 1985 Jan; 15(1):57-63. PubMed ID: 2981978
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Seroepidemiological studies of human T-lymphotropic retrovirus type III in acquired immunodeficiency syndrome.
    Safai B; Sarngadharan MG; Groopman JE; Arnett K; Popovic M; Sliski A; Schüpbach J; Gallo RC
    Lancet; 1984 Jun; 1(8392):1438-40. PubMed ID: 6145881
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Prevalence of antibodies against HTLV-III in various regions in Switzerland].
    Schüpbach J; Vogt M; Bhushan R; Lüthy R; Haller O; Joller H; Ferber T; Büchner S; Schuppli R; Schädelin J
    Schweiz Med Wochenschr; 1985 Jul; 115(30):1048-54. PubMed ID: 2994208
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sera from HTLV-III/LAV antibody-positive individuals mediate antibody-dependent cellular cytotoxicity against HTLV-III/LAV-infected T cells.
    Rook AH; Lane HC; Folks T; McCoy S; Alter H; Fauci AS
    J Immunol; 1987 Feb; 138(4):1064-7. PubMed ID: 3027168
    [TBL] [Abstract][Full Text] [Related]  

  • 13. IgG-antibodies to HTLV-III in patients with AIDS, LAS, and persons at risk of AIDS in West Germany.
    Hehlmann R; Kreeb G; Erfle V; Piechowiak H; Krüger G; Goebel FD
    Blut; 1985 Jan; 50(1):13-8. PubMed ID: 2981593
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interleukin 2 production and responsiveness in individuals with acquired immunodeficiency syndrome and the generalized lymphadenopathy syndrome.
    Borzy MS
    Cell Immunol; 1987 Jan; 104(1):142-53. PubMed ID: 3492294
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The relationship of abnormalities of cellular immunity to antibodies to HTLV-III in homosexual men.
    Dobozin BS; Judson FN; Cohn DL; Penley KA; Rickmann PE; Blaser MJ; Sarin PS; Weiss SH; Kirkpatrick CH
    Cell Immunol; 1986 Mar; 98(1):156-71. PubMed ID: 3017581
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Counterimmunoelectrophoresis for detection of human serum antibody to HTLV-III.
    Blaser MJ; Cohn DL; Cody HJ; Penley KA; Judson FN; Saxinger WC; Weiss SH
    J Immunol Methods; 1986 Jul; 91(2):181-6. PubMed ID: 3016097
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serological differences between human T-lymphotropic virus type-I (HTLV-I) and HTLV-III/LAV.
    Harada S; Purtilo DT; Koyanagi Y; Yamamoto N
    Microbiol Immunol; 1986; 30(6):533-44. PubMed ID: 3018457
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Autologous mixed lymphocyte reaction in man. XIV. Deficiency of the autologous mixed lymphocyte reaction in acquired immune deficiency syndrome (AIDS) and AIDS related complex (ARC). In vitro effect of purified interleukin-1 and interleukin-2.
    Gupta S; Gillis S; Thornton M; Goldberg M
    Clin Exp Immunol; 1984 Nov; 58(2):395-401. PubMed ID: 6238734
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cell-mediated immunity to cytomegalovirus (CMV) and herpes simplex virus (HSV) antigens in the acquired immune deficiency syndrome: interleukin-1 and interleukin-2 modify in vitro responses.
    Sheridan JF; Aurelian L; Donnenberg AD; Quinn TC
    J Clin Immunol; 1984 Jul; 4(4):304-11. PubMed ID: 6086703
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunological and virological investigation in patients with lymphoadenopathy syndrome and in a population at risk for acquired immunodeficiency syndrome (AIDS), with particular focus on the detection of antibodies to human T-lymphotropic retroviruses (HTLV III).
    Sirianni MC; Rossi P; Scarpati B; Ragona G; Seminara R; Bonomo G; Aiuti F
    J Clin Immunol; 1985 Jul; 5(4):261-8. PubMed ID: 2995433
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.